Comparison of Balloon Guide Catheters and Standard Guide Catheters for Acute Ischemic Stroke: An Updated Systematic Review and Meta-analysis

医学 改良兰金量表 优势比 溶栓 随机对照试验 荟萃分析 冲程(发动机) 脑梗塞 内科学 外科 缺血性中风 心肌梗塞 缺血 机械工程 工程类
作者
John M. Pederson,Nicole Hardy,Hannah Lyons,Erin Sheffels,Jillienne C. Touchette,Waleed Brinjikji,David F. Kallmes,Kevin M. Kallmes
出处
期刊:World Neurosurgery [Elsevier]
卷期号:185: 26-44
标识
DOI:10.1016/j.wneu.2024.01.110
摘要

To update our 2021 systematic review and meta-analysis which reported that balloon guide catheters (BGC) are associated with superior clinical and angiographic outcomes compared to standard guide catheters for treatment of acute ischemic stroke (AIS). We conducted a systematic review of seven electronic databases to identify literature published between January 2010 to September 2023 reporting BGC versus non-BGC approaches. Primary outcomes were final modified Thrombolysis in Cerebral Infarction (mTICI) ≥2b, first-pass effect (FPE; mTICI ≥2c on first pass), and modified Rankin Scale (mRS) 0-2 at 90 days. Risk of bias was assessed using the Newcastle Ottawa Scale. A separate random effects model was fit for each outcome. Subgroup analyses by first-line approach were conducted, with a separate random effects model on each subgroup. Twenty-four studies comprising 8,583 patients were included (4,948 BGC; 3,635 non-BGC; 1,561 BGC+Stent-retriever; 1,297 non-BGC+Stent-retriever). Nine studies had low-risk of bias, 3 were moderate-risk, and 12 were high-risk. Patients treated with BGCs had higher odds of achieving mTICI 2b/3, FPE mTICI 2c/3, and mRS 0-2 at 90 days (p<0.001). BGC+Stent-retriever was associated with higher odds of mTICI≥2b, 90-day mRS 0-2, and reduced odds of 90-day mortality compared to non-BGC+Stent-retrievers. The number needed to treat to achieve one additional successful recanalization is 17. The main limitation was the absence of randomized trials. These findings corroborate our previous results suggesting that MT using BGCs is associated with better safety and effectiveness outcomes for AIS, especially BGC+Stent-retrievers.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
hhhhhhl完成签到,获得积分10
刚刚
刚刚
1秒前
星辰大海应助莫铭采纳,获得30
1秒前
不羁的风完成签到 ,获得积分10
1秒前
舟舟发布了新的文献求助20
2秒前
梨小7完成签到,获得积分10
3秒前
4秒前
勤奋高丽发布了新的文献求助10
4秒前
光亮的思天完成签到,获得积分10
4秒前
5秒前
教授驳回了慕青应助
5秒前
无情修杰发布了新的文献求助10
5秒前
6秒前
Ganlou应助亮山火马采纳,获得20
7秒前
8秒前
8秒前
Orange应助向阳采纳,获得10
8秒前
huaner完成签到,获得积分10
8秒前
朝阳完成签到 ,获得积分10
8秒前
8秒前
9秒前
朴实如波发布了新的文献求助10
9秒前
9秒前
禾火发布了新的文献求助30
10秒前
QhL发布了新的文献求助10
10秒前
云阳完成签到,获得积分10
10秒前
10秒前
小熊薇薇薇完成签到 ,获得积分10
11秒前
11秒前
hhhhhhl发布了新的文献求助10
11秒前
11秒前
ryg发布了新的文献求助10
12秒前
病理小白完成签到,获得积分10
12秒前
12秒前
Lipeng发布了新的文献求助10
12秒前
13秒前
情怀应助高分子狗采纳,获得10
14秒前
六阳应助无情修杰采纳,获得10
14秒前
萝卜特二发布了新的文献求助10
15秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Effect of reactor temperature on FCC yield 2000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
Impiego dell’associazione acetazolamide/pentossifillina nel trattamento dell’ipoacusia improvvisa idiopatica in pazienti affetti da glaucoma cronico 900
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
錢鍾書楊絳親友書札 600
金属中的晶界偏聚 450
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3296766
求助须知:如何正确求助?哪些是违规求助? 2932428
关于积分的说明 8456797
捐赠科研通 2604920
什么是DOI,文献DOI怎么找? 1422116
科研通“疑难数据库(出版商)”最低求助积分说明 661288
邀请新用户注册赠送积分活动 644372